Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.

LON:IQE - IQE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 78.38
  • Forecasted Upside: 26.47 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 61.97
▼ -2.731 (-4.22%)
1 month | 3 months | 12 months
Get New IQE Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IQE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IQE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 78.38
▲ +26.47% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for IQE in the last 3 months. The average price target is GBX 78.38, with a high forecast of GBX 105 and a low forecast of GBX 55. The average price target represents a 26.47% upside from the last price of GBX 61.97.
Streaming Stocks are Surging
Canadian Live Streaming Stock Set To Win In China & Middle East.
Buy
The current consensus among 4 investment analysts is to buy stock in IQE. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/21/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/19/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/18/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/17/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/15/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/13/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/14/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
4/14/2021BarclaysReiterated RatingEqual Weight
i
4/14/2021Deutsche Bank AktiengesellschaftLower Price TargetBuyGBX 100 ➝ GBX 80
i
1/26/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuyGBX 90 ➝ GBX 100
i
10/14/2020Canaccord GenuityReiterated RatingSpeculative Buy
i
9/10/2020Canaccord GenuityBoost Price TargetSpeculative BuyGBX 70 ➝ GBX 73.50
i
7/13/2020BarclaysDowngradeEqual weightGBX 55
i
6/16/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuyGBX 45 ➝ GBX 60
i
6/15/2020Canaccord GenuityBoost Price TargetSpeculative BuyGBX 60 ➝ GBX 70
i
6/12/2020Peel HuntBoost Price TargetBuyGBX 95 ➝ GBX 105
i
5/18/2020Canaccord GenuityReiterated RatingSpeculative BuyGBX 60
i
4/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuyGBX 40 ➝ GBX 45
i
4/28/2020Peel HuntReiterated RatingBuy
i
4/16/2020Peel HuntReiterated RatingBuy
i
4/8/2020Deutsche Bank AktiengesellschaftUpgradeBuy
i
3/27/2020Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 50 ➝ GBX 40
i
3/24/2020Peel HuntReiterated RatingBuy
i
3/10/2020Peel HuntLower Price TargetBuyGBX 108 ➝ GBX 95
i
2/24/2020Peel HuntReiterated RatingBuy
i
1/16/2020BarclaysDowngradeEqual weightGBX 73 ➝ GBX 55
i
12/18/2019Peel HuntReiterated RatingBuy
i
11/21/2019Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 64 ➝ GBX 50
i
11/19/2019Canaccord GenuityLower Price TargetSpeculative BuyGBX 80 ➝ GBX 65
i
11/19/2019BarclaysLower Price TargetOverweightGBX 80 ➝ GBX 73
i
11/14/2019Peel HuntReiterated RatingBuyGBX 108
i
11/14/2019Peel HuntReiterated RatingBuyGBX 108
i
10/11/2019BarclaysReiterated RatingOverweight
i
10/10/2019Peel HuntReiterated RatingBuyGBX 108
i
10/8/2019Peel HuntReiterated RatingBuyGBX 108
i
9/12/2019Canaccord GenuityDowngradeSpeculative BuyGBX 85 ➝ GBX 80
i
9/9/2019Peel HuntReiterated RatingBuy
i
9/2/2019Peel HuntReiterated RatingBuy
i
8/30/2019Canaccord GenuityReiterated RatingBuyGBX 85
i
8/5/2019Peel HuntReiterated RatingBuy
i
7/23/2019Peel HuntReiterated RatingBuy
i
7/12/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
7/4/2019Peel HuntReiterated RatingBuy
i
7/3/2019Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 70 ➝ GBX 64
i
7/1/2019Canaccord GenuityReiterated RatingBuyGBX 85
i
6/21/2019Peel HuntReiterated RatingBuyGBX 108
i
6/21/2019Canaccord GenuityLower Price TargetBuyGBX 130 ➝ GBX 85
i
6/21/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
6/17/2019Peel HuntReiterated RatingBuyGBX 137 ➝ GBX 108
i
5/28/2019BarclaysLower Price TargetOverweightGBX 84 ➝ GBX 80
i
5/24/2019Peel HuntReiterated RatingBuy
i
5/21/2019Canaccord GenuityReiterated RatingBuyGBX 130
i
5/8/2019Canaccord GenuityBoost Price TargetBuyGBX 120 ➝ GBX 130
i
5/2/2019Peel HuntReiterated RatingBuy
i
4/15/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
4/9/2019Peel HuntReiterated RatingBuy
i
3/27/2019Peel HuntReiterated RatingBuy
i
3/22/2019Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 80 ➝ GBX 70
i
3/20/2019Peel HuntReiterated RatingBuy
i
2/4/2019Peel HuntReiterated RatingBuy
i
1/25/2019Peel HuntReiterated RatingBuy
i
1/17/2019BarclaysReiterated RatingOverweight
i
12/6/2018Canaccord GenuityReiterated RatingBuyGBX 152
i
11/30/2018Peel HuntReiterated RatingBuy
i
11/16/2018BarclaysLower Price TargetOverweightGBX 170 ➝ GBX 84
i
11/14/2018Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 100 ➝ GBX 80
i
11/13/2018Peel HuntReiterated RatingBuyGBX 154 ➝ GBX 137
i
11/2/2018Peel HuntReiterated RatingBuy
i
10/15/2018Peel HuntReiterated RatingBuy
i
10/2/2018Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 110 ➝ GBX 100
i
10/1/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
10/1/2018Peel HuntReiterated RatingBuy
i
9/19/2018Peel HuntInitiated CoverageBuyGBX 154
i
9/12/2018Deutsche Bank AktiengesellschaftReiterated RatingHold
i
8/30/2018BarclaysReiterated RatingOverweightGBX 170
i
8/30/2018Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 115 ➝ GBX 110
i
8/29/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
8/29/2018Peel HuntReiterated RatingBuy
i
8/15/2018BarclaysLower Price TargetOverweightGBX 210 ➝ GBX 170
i
8/1/2018Peel HuntReiterated RatingBuy
i
7/26/2018Deutsche Bank AktiengesellschaftReiterated RatingHold
i
7/24/2018Peel HuntReiterated RatingBuy
i
7/13/2018Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 140 ➝ GBX 115
i
7/9/2018Peel HuntReiterated RatingBuy
i
7/3/2018Peel HuntReiterated RatingBuy
i
7/2/2018BarclaysReiterated RatingOverweight
i
6/4/2018Peel HuntReiterated RatingBuy
i
5/2/2018Peel HuntReiterated RatingBuyGBX 170
i
4/3/2018Peel HuntReiterated RatingBuy
i
3/23/2018CitigroupReiterated RatingBuyGBX 195
i
3/20/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
3/20/2018Peel HuntLower Price TargetBuyGBX 188 ➝ GBX 170
i
2/26/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
2/22/2018CitigroupReiterated RatingBuyGBX 195
i
2/22/2018Peel HuntReiterated RatingBuyGBX 188
i
2/9/2018Peel HuntReiterated RatingBuyGBX 188
i
2/8/2018Stifel NicolausReiterated RatingBuyGBX 185
i
2/6/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
2/2/2018Peel HuntReiterated RatingBuyGBX 188
i
1/12/2018BarclaysReiterated RatingOverweightGBX 210
i
1/12/2018Deutsche Bank AktiengesellschaftInitiated CoverageHoldGBX 140
i
1/5/2018Canaccord GenuityReiterated RatingBuyGBX 190
i
12/21/2017N+1 SingerReiterated RatingBuyGBX 181
i
12/21/2017CitigroupReiterated RatingBuyGBX 195
i
12/20/2017Peel HuntReiterated RatingBuyGBX 188
i
12/4/2017CitigroupReiterated RatingBuyGBX 195
i
12/4/2017BarclaysInitiated CoverageOverweightGBX 210
i
11/10/2017CitigroupInitiated CoverageBuyGBX 195
i
11/2/2017Peel HuntBoost Price TargetBuyGBX 150 ➝ GBX 188
i
9/13/2017Peel HuntReiterated RatingBuyGBX 150
i
9/5/2017Canaccord GenuityReiterated RatingBuyGBX 180
i
9/5/2017Peel HuntBoost Price TargetBuyGBX 135 ➝ GBX 150
i
8/10/2017Peel HuntBoost Price TargetBuyGBX 105 ➝ GBX 135
i
7/20/2017Canaccord GenuityUpgradeBuyGBX 118 ➝ GBX 128
i
7/20/2017Peel HuntBoost Price TargetBuyGBX 100 ➝ GBX 105
i
6/26/2017Canaccord GenuityDowngradespeculative buyGBX 69 ➝ GBX 118
i
6/13/2017Peel HuntBoost Price TargetBuyGBX 62 ➝ GBX 100
i
3/22/2017Peel HuntUpgradeBuyGBX 35 ➝ GBX 60
i
3/21/2017N+1 SingerReiterated RatingBuy
i
3/21/2017Canaccord GenuityBoost Price TargetBuyGBX 51 ➝ GBX 69
i
1/12/2017N+1 SingerReiterated RatingBuyGBX 48
i
1/4/2017N+1 SingerReiterated RatingBuyGBX 48
i
12/14/2016Peel HuntDowngradeHoldGBX 33 ➝ GBX 35
i
11/18/2016Canaccord GenuityBoost Price TargetBuyGBX 40 ➝ GBX 51
i
11/10/2016Peel HuntReiterated RatingBuyGBX 33
i
10/19/2016N+1 SingerReiterated RatingBuyGBX 35
i
9/15/2016N+1 SingerReiterated RatingBuyGBX 35
i
9/13/2016Canaccord GenuityBoost Price TargetBuyGBX 30 ➝ GBX 40
i
9/13/2016Peel HuntReiterated RatingBuyGBX 33
i
8/25/2016Peel HuntReiterated RatingBuyGBX 30
i
8/15/2016Canaccord GenuityReiterated RatingBuyGBX 30
i
7/26/2016Canaccord GenuityReiterated RatingBuyGBX 30
i
7/20/2016Peel HuntReiterated RatingBuyGBX 30
i
6/7/2016Canaccord GenuityReiterated RatingBuyGBX 30
i
5/4/2016Peel HuntReiterated RatingBuyGBX 30
i
(Data available from 4/14/2016 forward)
IQE logo
IQE plc develops, manufactures, and sells advanced semiconductor materials. The company operates through Wireless, Photonics, and CMOS++ segments. It manufactures compound semiconductor wafers or epiwafers using epitaxy process; and offers various products, including HBTs, pHEMTs, BiFETs/BiHEMTs, HFETs, LMHEMTs, LNHEMTs, and MESFETs for use in electronic devices, such as mobile phones, smartphones, mobile networks, Wi-Fi, smart metering, satellite navigation, and a plethora of connected devices. The company also provides a range of wafers comprising optical fiber communications optical storage solutions consisting of CDs and DVDs; optical networking solutions, including storage area networks; computing solutions, such as optical mouse devices and CD/DVD ROMs; office/professional solutions comprising laser printing/copying; and energy solutions consisting of solar cells for emitters and detectors, infrared, solar, optical interconnects, laser projection, gesture recognition, solid state lighting applications. In addition, it offers IR sensor, thermal imaging, night vision, and thermal photovoltaic products for infrared applications; and compound semiconductor solar cells and panels for utility scale electricity generation, satellite/space power generation, power generation, and power applications. Further, the company produces compound semiconductor on silicon wafers; and engineered substrates for next-generation microprocessors, and ultra high speed/density flash memory and MEMs devices. Additionally, it provides gallium nitride, a compound semiconductor, which includes a range of RF, photonic, and electronic properties. The company serves in the United States, rest of the Americas, France, Germany, Israel, the United Kingdom, rest of Europe, the Middle East, Africa, the People's Republic of China, Japan, Taiwan, and rest of the Asia-Pacific. IQE plc was founded in 1988 and is headquartered in Cardiff, the United Kingdom.
Read More

Today's Range

Now: GBX 61.97
61.90
65

50 Day Range

MA: GBX 68.60
56.45
78.55

52 Week Range

Now: GBX 61.97
28.56
91.94

Volume

1,751,772 shs

Average Volume

4,068,020 shs

Market Capitalization

£496.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of IQE?

The following Wall Street sell-side analysts have issued reports on IQE in the last twelve months: Barclays PLC, Canaccord Genuity, Deutsche Bank Aktiengesellschaft, and Peel Hunt.
View the latest analyst ratings for IQE.

What is the current price target for IQE?

4 Wall Street analysts have set twelve-month price targets for IQE in the last year. Their average twelve-month price target is GBX 78.38, suggesting a possible upside of 24.6%. Peel Hunt has the highest price target set, predicting IQE will reach GBX 105 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of GBX 55 for IQE in the next year.
View the latest price targets for IQE.

What is the current consensus analyst rating for IQE?

IQE currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IQE will outperform the market and that investors should add to their positions of IQE.
View the latest ratings for IQE.

What other companies compete with IQE?

How do I contact IQE's investor relations team?

IQE's physical mailing address is Pascal Close, CARDIFF, CF3 0LW, United Kingdom. The company's listed phone number is +44-29-20839400. The official website for IQE is www.iqep.com.

Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.